Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: S&P Capital IQ Quantitative Report
$127.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Auxilium Pharmaceuticals Inc Raises FY 2012 Guidance


Wednesday, 7 Nov 2012 07:00am EST 

Auxilium Pharmaceuticals Inc announced that it is increasing its fiscal 2012 guidance for total net revenues from the previously stated guidance of a range of $310 million to $332 million to a range of $388 million to $408 million and is also increasing fiscal 2012 GAAP net income guidance from the previously stated guidance of a range of $0 million to $(5) million to a range of $85 million to $90 million. 

Company Quote

30.15
-0.14 -0.46%
10:34am EDT